Key result
Video motion analysis with field potentials effectively tracks drug-induced cardiomyocyte functional changes.
Why the study?
Certain pharmacological effects on cardiac tissues are not accurately reflected in field potential waveform alterations measured by multi electrode arrays, necessitating improved measurement and interpretation methods.
Reports on the use multi electrode arrays (MEA) systems for screening the electrophysiological effects of drug candidates on cardiac tissues as a response to the need of the pharmaceutical industry for a high-throughput screening method have increased in the past decades.Though the field potential (FP) measured in MEA have been reported coherent to the progression of the well-established progression of action potential (AP), certain pharmacological effects do not accurately reflect in the observed FP waveform alteration.Here, we revisit the imaging analysis algorithm developed in our lab based on the pixel intensity variation that can be utilized to improve the FP measurement and interpretation.Imaging analysis was done on videos recorded with a microscope camera at 30 Hz frame rate and 680 × 510 pixel resolution resulting to a relative lower system requirement compared to other methods.It is expected that combining our method with MEA systems can greatly aid in developing a screening platform for cardiovascular effect profiling of candidate drugs.
No takes yet. Share an insight, caveat, or question.
Espulgar et al. (2016) studied In vitro cardiac tissue drug screening. Cardioactive drugs (verapamil, propranolol, quinidine, sotalol) vs. Pre-administration baseline was evaluated. The non-invasive video image-based analysis method, coupled with field potential recordings, effectively quantified the chronotropic effects and contractile behavior of cardiomyocyte tissues in response to various cardioactive drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: